A new study revealed that the adverse overall survival impact of TAMs in classical Hodgkin lymphoma (cHL) is dependent on checkpoint expression, especially on programmed death ligand 1 (PD-L1) and indoleamine 2,3-dioxygenase (IDO-1) expression (11). Here, IDO2 is linked to classic Hodgkin lymphoma.